Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea

Figures

• 

  Figure 1. Flowchart of the study.

• 

  Figure 2. Incidence of lung cancer in the whole cohort (A) adjusted for sex and age and (B) PS stratified. AUMC Ajou University Medical Center, DCMC Daegu Catholic University Medical Center, KNUH Kangwon National University Hospital, KDH Kangdong Sacred Heart Hospital, KHNMC Kyung Hee University Hospital at Gangdong, PNUH Pusan National University Hospital, WKUH Wonkwang University Hospital, TE estimated effect, seTE standard error of individual studies, HR hazard ratio, CI confidence interval, ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker.

• 

  Figure 3. Incidence of lung cancer in the propensity-score matched population. AUMC Ajou University Medical Center, DCMC Daegu Catholic University Medical Center, KNUH Kangwon National University Hospital, KDH Kangdong Sacred Heart Hospital, KHNMC Kyung Hee University Hospital at Gangdong, PNUH Pusan National University Hospital, WKUH Wonkwang University Hospital, TE estimated effect, seTE standard error of individual studies, HR hazard ratio, CI confidence interval, ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker.